These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4321640)

  • 1. The partial purification and some biological activities of histamine sensitizing factor from Bordetella pertussis.
    Homma R; Kuratsuka K; Shimazaki Y; Funasaka I
    Jpn J Med Sci Biol; 1970 Aug; 23(4):277-81. PubMed ID: 4321640
    [No Abstract]   [Full Text] [Related]  

  • 2. Partial purification and some properties of the leukocytosis-promoting material from Bordetella pertussis.
    Sato Y; Arai H
    Jpn J Med Sci Biol; 1970 Aug; 23(4):273-6. PubMed ID: 4099421
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cell components of Bordetella pertussis and their biological activities].
    Sato Y; Arai H
    Tanpakushitsu Kakusan Koso; 1972; 17(2):139-49. PubMed ID: 4337077
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphocytosis-promoting factor produced by Bordetella pertussis. Partial purification and characterization.
    Uiwasa S; Ishida S; Asakawa S; Kurokawa M
    Jpn J Med Sci Biol; 1968 Oct; 21(5):363-8. PubMed ID: 4304392
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental relation between histamine-sensitizing factor and the protective antigen of Bordetella pertussis].
    Jiménez Paredes J; Ruiz Puente J; González Pacheco M
    Salud Publica Mex; 1981; 23(6):621-9. PubMed ID: 6278660
    [No Abstract]   [Full Text] [Related]  

  • 6. Polymorphonuclear leukocyte-inhibitory factor of Bordetella pertussis. I. Extraction and partial purification of phagocytosis- and chemotaxis-inhibitory activities.
    Utsumi S; Sonoda S; Imagawa T; Kanoh M
    Biken J; 1978 Dec; 21(4):121-35. PubMed ID: 224858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat-labile toxin of Bordetella pertussis purified by preparative acrylamide gel electrophoresis.
    Nakase Y; Takatsu K; Tateishi M; Sekiya K; Kasuga T
    Jpn J Microbiol; 1969 Dec; 13(4):359-66. PubMed ID: 4311586
    [No Abstract]   [Full Text] [Related]  

  • 8. Morphological alterations of the adrenal gland following administration of histamine-sensitizing-factor of Bordetella pertussis.
    Kuwajima Y
    Osaka City Med J; 1980; 26(1):61-6. PubMed ID: 6267538
    [No Abstract]   [Full Text] [Related]  

  • 9. Attempts at isolation of lymphocytosis-producing factor from supernatant fluids of Bordetella pertussis cultures.
    Okuyama S; Aronson RB; Chanana AD; Cronkite EP; Rai KR; Schiffer LM
    Proc Soc Exp Biol Med; 1970 Feb; 133(2):723-7. PubMed ID: 4313155
    [No Abstract]   [Full Text] [Related]  

  • 10. Some histamine sensitizing properties of soluble preparations of the histamine sensitizing factor(HSF) from Bordetella pertussis.
    Munoz J; Bergman RK
    J Immunol; 1966 Jul; 97(1):120-5. PubMed ID: 4288348
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Comparison between histamine-sensitizing factor of Bordetella pertussis and bacterial endotoxin in respect to histamine-sensitizing activity.
    Kuratsuka K; Homma R
    Jpn J Med Sci Biol; 1975; 28(5-6):316-20. PubMed ID: 180321
    [No Abstract]   [Full Text] [Related]  

  • 12. Outline of purification and some properties of histamine-sensitizing factor from Bordetella pertussis.
    Homma R; Shimazaki Y; Funasaka I; Kuratsuka K
    Jpn J Med Sci Biol; 1969 Apr; 22(2):123-6. PubMed ID: 4310288
    [No Abstract]   [Full Text] [Related]  

  • 13. The soluble protective antigen and the histamine-sensitizing factor of Bordetella pertussis.
    Pieroni RE; Broderick EJ; Levine L
    J Immunol; 1965 Oct; 95(4):643-50. PubMed ID: 4284676
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological activities of crystalline pertussigen from Bordetella pertussis.
    Munoz JJ; Arai H; Bergman RK; Sadowski PL
    Infect Immun; 1981 Sep; 33(3):820-6. PubMed ID: 6269999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of microbial toxins on the permeability of the blood-tissue barrier].
    Glezerov VZ
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Sep; 47(9):43-6. PubMed ID: 4326138
    [No Abstract]   [Full Text] [Related]  

  • 16. Crystallization of pertussigen from Bordetella pertussis.
    Arai H; Munoz JJ
    Infect Immun; 1981 Jan; 31(1):495-9. PubMed ID: 6260667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of heat-labile toxin of B. pertussis on mouse blood cells: the determination of LPF (leukocytosis-promoting factor)].
    Ishida S; Kurokawa M
    Igaku To Seibutsugaku; 1972 Apr; 84(4):255-9. PubMed ID: 4340315
    [No Abstract]   [Full Text] [Related]  

  • 18. [Morphological changes in the central nervous system of mice inoculated with a Bordetella pertussis suspension].
    Borowska-Lehman J; Kopacka B; Kuklińska D
    Neuropatol Pol; 1978; 16(3):318-26. PubMed ID: 212699
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of anaphylatoxin (AT) upon capillary permeability in guinea pig skin].
    Bodammer G; Vogt W
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(3):255-60. PubMed ID: 4193283
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on the toxins of Bordetella pertussis. 8. Pathohistologic studies on all organs of mice inoculated with pertussis toxin].
    KUROKOCHI T
    Nihon Saikingaku Zasshi; 1961 Dec; 16():1046-52. PubMed ID: 14460789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.